Search - tctmd.com

Displaying 361 - 380 of 735

Sort: Relevancy | Date

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Daily News

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Michael O'Riordan

October 12, 2018

News Daily News

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Todd Neale

October 09, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

News Daily News

Ronald G. Victor, Who Brought Hypertension Treatment Into the Barbershop, Dead at 66

Todd Neale

September 14, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Daily News

Physician Conflict of Interest Disclosures to Journals for Device-Industry Ties Fall Short

Caitlin E. Cox

August 24, 2018

News Daily News

Reducing CV Risk May Improve Brain Health at Any Stage in Life, Studies Hint

Todd Neale

August 22, 2018

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

News Features

Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere

Yael L. Maxwell

August 02, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

L.A. McKeown

May 23, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Advertisement

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Ronald G. Victor, Who Brought Hypertension Treatment Into the Barbershop, Dead at 66

MITRA-FR: No Benefit of MitraClip in Functional MR

Physician Conflict of Interest Disclosures to Journals for Device-Industry Ties Fall Short

Reducing CV Risk May Improve Brain Health at Any Stage in Life, Studies Hint

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content